The Nation’s First Publicly Recognized Overdose Prevention Centers: Lessons Learned in New York City
2023 · Journal of Urban Health · 31 citations
https://doi.org/10.1007/s11524-023-00717-y
A
Alex Harocopos
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
1.1K
Citations
14
h-index
19
i10-index
Alex Harocopos is an academic researcher from New York City Department of Health and Mental Hygiene. The author has contributed to research in topics: Opioid Use Disorder Treatment & HIV, Drug Use, Sexual Risk & Substance Abuse Treatment and Outcomes. The author has an h-index of 14, co-authored 38 publications.
ORCID: 0000-0002-4650-762XPapers by this author
worksHepatitis C knowledge among new injection drug users
2010 · Drugs Education Prevention and Policy · 13 citations
https://doi.org/10.3109/09687630902858948
Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation
2022 · Harm Reduction Journal · 12 citations
https://doi.org/10.1186/s12954-022-00654-0
Evaluation of Two Videos that Apply Evidence-Based Strategies to Increase Self-Efficacy and Reduce Opioid-Related Stigma Among Medical Students
2024 · Academic Psychiatry · 4 citations
https://doi.org/10.1007/s40596-024-01945-3
Expanding buprenorphine prescribing in primary care: a qualitative study of the experiences of primary care providers and nurse care managers participating in the New York City buprenorphine nurse care manager initiative
2025 · Harm Reduction Journal · 0 citations
https://doi.org/10.1186/s12954-025-01271-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat